Breast Implant ALCL Lymphoma Side Effects. Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses. Are you a breast implant recipient whose been diagnosed with lymphoma?
The U.S. Food & Drug Administration (FDA) recently warned that both silicone and saline breast implants may be associated with anaplastic large cell lymphoma (ALCL), a rare form of cancer.
Our breast implant lymphoma lawyers are investigating this association, and we want to hear from any woman who was diagnosed with ALCL related to her breast implant.
Our breast implant lymphoma lawyers are offering free lawsuit evaluations to victims of this cancer. If you or a woman you love were diagnosed with lymphoma related to breast implants, you may be entitled to compensation for your medical bills, lost wages, pain and suffering and other damages. We urge you to contact one of our breast implant lymphoma lawyers today to protect your legal rights.
Breast Implant Lymphoma
In January 2011, The U.S. Food & Drug Administration (FDA) advised that women who had received breast implants should notify their doctors of any changes in their breasts because of a possible association with a rare type of lymphoma. In breast implant patients, ALCL has occurred in the scar capsule adjacent to the implant.
Symptoms of breast implant lymphoma include:
- Pain
- Lumps
- Swelling
- Asymmetry that developed after their initial surgical sites were fully healed
These symptoms were due to collection of fluid (peri-implant seroma), hardening of breast area around the implant (capsular contracture), or masses surrounding the breast implant. Examination of the fluid and capsule surrounding the breast implant led to the ALCL diagnosis, the FDA said.
ALCL is a rare malignant tumor (non-Hodgkin lymphoma) that may appear in several parts of the body including the lymph nodes, skin, bones, soft tissue, lungs or liver. Each year ALCL is diagnosed in about 1 out of 500,000 women in the United States. ALCL located in breast tissue is found in only about 3 out of every 100 million women nationwide without breast implants.
The FDA notification was based on a review of scientific literature published between January 1997 and May 2010 and information from other international regulators, scientists, and breast implant manufacturers. The literature review identified 34 unique cases of ALCL in women with both saline and silicone breast implants.
In total, the FDA is aware of about 60 cases of ALCL in women with breast implants worldwide. The agency said the number is difficult to verify because not all cases were published in the scientific literature and some may be duplicate reports. The FDA is requesting that health care professionals report any confirmed cases of ALCL in women with breast implants.
The FDA said it is working with breast implant manufacturers to update their product labeling to address this lymphoma risk. The agency recommended that health care professionals and women pay close attention to breast implants. Breast implant recipients should contact their doctor if they notice any changes, and women considering breast implants should discuss the risk of ALCL with their doctors.
Need Legal Help Regarding Breast Implant ALCL Lymphoma?
If you or a loved one was diagnosed with lymphoma related to breast implants, you may have valuable legal rights. To discuss your case with one of our breast implant lymphoma lawyers, please fill out our online form, or call 1-800-YOURLAWYER (1-800-968-7529) today.
